Axsome Therapeutics (AXSM) Intangibles (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Intangibles data on file, last reported at $38.9 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 14.07% year-over-year to $38.9 million; the trailing twelve-month figure through Mar 2026 stood at $38.9 million (down 14.07% YoY), and the FY2025 full-year result was $63.8 million, up 36.05% from the prior year.
• Intangibles slipped to $38.9 million in Q1 2026, from $63.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $63.8 million in Q2 2022 to a low of $38.9 million in Q1 2026.
• A 5-year average of $55.2 million and a median of $57.3 million in 2023 frame the typical range for Intangibles.
• Peak annual rise in Intangibles reached 36.05% in 2025, while the deepest fall reached 33.97% in 2025.
• Tracing AXSM's Intangibles over 5 years: stood at $63.8 million in 2022, then changed by 0.0% to $63.8 million in 2023, then dropped by 26.5% to $46.9 million in 2024, then surged by 36.05% to $63.8 million in 2025, then plunged by 38.95% to $38.9 million in 2026.
• Business Quant data shows AXSM's Intangibles at $38.9 million in Q1 2026, $63.8 million in Q4 2025, and $42.1 million in Q3 2025.